FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.10  |  FHIR Version n/a  User: [n/a]

400332006: Aminophylline hydrate 350mg modified-release tablet (product)

    Status: retired, Not sufficiently defined by necessary conditions definition status. Date: 31-Jul 2008. Module: SNOMED CT core module

    Descriptions:

    Id Description Lang Type Status Case? Module
    1768252015 Aminophylline hydrate 350mg modified-release tablet (product) en Fully specified name Active Entire term case insensitive SNOMED CT core module
    1779574017 Aminophylline hydrate 350mg modified-release tablet en Synonym Active Entire term case insensitive SNOMED CT core module

    0 descendants.

    Expanded Value Set

    Outbound Relationships Type Target Active Characteristic Refinability Group Values
    Aminophylline hydrate 350mg modified-release tablet Is a Aminophylline m/r tablet false Inferred relationship Existential restriction modifier
    Aminophylline hydrate 350mg modified-release tablet Has active ingredient Aminophylline false Inferred relationship Existential restriction modifier
    Aminophylline hydrate 350mg modified-release tablet Has active ingredient Smooth muscle relaxant false Inferred relationship Existential restriction modifier
    Aminophylline hydrate 350mg modified-release tablet Has active ingredient Substance with phosphodiesterase inhibitor mechanism of action false Inferred relationship Existential restriction modifier
    Aminophylline hydrate 350mg modified-release tablet Has manufactured dose form Tablet false Inferred relationship Existential restriction modifier
    Aminophylline hydrate 350mg modified-release tablet Has active ingredient Xanthine false Inferred relationship Existential restriction modifier
    Aminophylline hydrate 350mg modified-release tablet Has active ingredient Musculoskeletal system agent false Inferred relationship Existential restriction modifier
    Aminophylline hydrate 350mg modified-release tablet Has manufactured dose form Oral dose form false Inferred relationship Existential restriction modifier
    Aminophylline hydrate 350mg modified-release tablet Has manufactured dose form Conventional release oral tablet false Inferred relationship Existential restriction modifier
    Aminophylline hydrate 350mg modified-release tablet Has active ingredient Aminophylline hydrate false Inferred relationship Existential restriction modifier
    Aminophylline hydrate 350mg modified-release tablet Has manufactured dose form Modified-release tablet false Inferred relationship Existential restriction modifier
    Aminophylline hydrate 350mg modified-release tablet Has manufactured dose form Modified-release oral tablet false Inferred relationship Existential restriction modifier
    Aminophylline hydrate 350mg modified-release tablet Has active ingredient Aminophylline hydrate false Inferred relationship Existential restriction modifier
    Aminophylline hydrate 350mg modified-release tablet VMP prescribing status (attribute) VMP valid as a prescribable product false Inferred relationship Existential restriction modifier
    Aminophylline hydrate 350mg modified-release tablet VMP non-availability indicator Available false Inferred relationship Existential restriction modifier
    Aminophylline hydrate 350mg modified-release tablet Has manufactured dose form Modified-release oral tablet false Inferred relationship Existential restriction modifier
    Inbound Relationships Type Active Source Characteristic Refinability Group
    Phyllocontin Forte Continus 350mg tablets (Napp Pharmaceuticals Ltd) Is a False Aminophylline hydrate 350mg modified-release tablet Inferred relationship Existential restriction modifier
    Aminophylline hydrate 350mg modified-release tablets 56 tablet Is pack of False Aminophylline hydrate 350mg modified-release tablet Inferred relationship Existential restriction modifier

    This concept is not in any reference sets

    Back to Start